At the last major DC showdown with big pharma, we learned a crucial fact about US drug prices. It's sure to come up again this week.

Pharma CEOs are likely to blame drug rebates for the high cost of their treatments, echoing an argument the industry has been using frequently.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

BusinessInsider /  🏆 729. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

New round of US-China trade talks to begin in DCHigher-level negotiations will take place on Thursday and Friday after efforts in Beijing last week came to a head without any deal or resolution to a fight over Beijing's technology ambitions ahead of a deadline for a massive US tariff hike.
Baca lebih lajut »

Winter Storm Disrupts Travel and Work in Washington, D.C.A winter storm dumped snow across the nation’s capital and surrounding region Wednesday morning, grounding hundreds of flights, closing government offices and slowing morning commutes.
Baca lebih lajut »